Edgar Tracker

NVO NOVO NORDISK A S

NYSE, OTC · CIK 353278 · Pharmaceutical Preparations

SEC company page

Public articles

NVO notes

Company note

Novo Nordisk: Obesity momentum must earn back the pipeline premium Novo Nordisk’s diabetes and obesity business still produces substantial operating profit, but its valuation need…

Recent filings

–

Form Filed Title Accession
6-K2026-10-26FORM 6-K0001171843-26-006813
6-K2026-10-19FORM 6-K0001171843-26-006685
6-K2026-10-13FORM 6-K0001171843-26-006585
6-K2026-10-06FORM 6-K0001171843-26-006440
6-K2026-10-05FORM 6-K0001171843-26-006374
6-K2026-09-28FORM 6-K0001171843-26-006248
6-K2026-09-21FORM 6-K0001171843-26-006128
6-K2026-09-17FORM 6-K0001171843-26-006088
6-K2026-09-15FORM 6-K0001171843-26-006038
6-K2026-09-09FORM 6-K0001171843-26-005925
6-K2026-08-31FORM 6-K0001171843-26-005795
6-K2026-08-24FORM 6-K0001171843-26-005715
6-K2026-08-18FORM 6-K0001171843-26-005599
6-K2026-08-10FORM 6-K0001171843-26-005376
6-K2026-08-10FORM 6-K0001171843-26-005375
6-K2026-08-046-K0000353278-26-000023
6-K2026-08-046-K0001171843-26-005184
6-K2026-08-04FORM 6-K0001171843-26-005172
6-K2026-07-31FORM 6-K0001171843-26-005109
6-K2026-07-27FORM 6-K0001171843-26-004880